cGAS-STING Targeting Offers Novel Therapeutic Opportunities in Liver Diseases
Open Access
- 1 July 2025
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 19, 5835-5853
Abstract
Cyclic GMP/AMP (cGAMP) synthase (cGAS), coupled with the endoplasmic reticulum (ER)-anchored adaptor protein stimulator of interferon genes (STING), constitute key components of the type 1 interferon signaling network. cGAS detects both pathogen-derived DNA and aberrant cytosolic self-DNA, establishing the cGAS-STING pathway as a central player in autoimmune disorders, sterile inflammation, and senescence-related processes. However, sustained abnormal activation of this signaling axis is implicated in the pathogenesis of chronic inflammatory and autoimmune conditions. Recent studies have uncovered the pivotal role of cGAS-STING signaling in driving inflammation-associated pathologies, particularly hepatic disorders. Advances in understanding the molecular dynamics of this pathway have facilitated the development of targeted small-molecule inhibitors with therapeutic potential for cGAS-STING-driven liver diseases. In this review, we first delineate the core architecture of the cGAS-STING signaling cascade. Building on this framework, we analyze emerging evidence elucidating the mechanistic contributions of cGAS-STING activation to hepatic pathophysiology. Subsequently, we catalog pharmacologically active compounds capable of modulating this pathway in liver disease models. Finally, we critically evaluate current challenges in translating cGAS-STING-targeted therapies and propose strategic approaches to address these limitations. This synthesis underscores innovative therapeutic opportunities arising from precision modulation of the cGAS-STING axis in liver diseases.Keywords
This publication has 128 references indexed in Scilit:
- PPM1G regulates hepatic ischemia/reperfusion injury through STING‐mediated inflammatory pathways in macrophagesImmunity, Inflammation and Disease, 2024
- Manganese Exacerbates ConA-Induced Liver Inflammation via the cGAS-STING Signaling PathwayInflammation, 2023
- P2rx1 deficiency alleviates acetaminophen-induced acute liver failure by regulating the STING signaling pathwayCell Biology and Toxicology, 2023
- Activation of cDCs and iNKT cells contributes to triptolide-induced hepatotoxicity via STING signaling pathway and endoplasmic reticulum stressCell Biology and Toxicology, 2022
- Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptationHepatology, 2022
- Loss of Sam50 in hepatocytes induces cardiolipin‐dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injuryHepatology, 2022
- STING‐mediated inflammation contributes to Gao binge ethanol feeding modelJournal of Cellular Physiology, 2021
- Emodin Attenuates Acetaminophen-Induced Hepatotoxicity via the cGAS-STING PathwayInflammation, 2021
- Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1–mediated p62/sequestosome 1 phosphorylationHepatology, 2017
- Evidence for a nuclear factor(s), IRF‐1, mediating induction and silencing properties to human IFN‐beta gene regulatory elements.The EMBO Journal, 1988